BMSC and CoQ10 improve behavioural recovery and histological outcome in rat model of Parkinson's disease

Pathophysiology

Volumn 18, Issue 4, 2011, Pages 317-324

  Nezhadi, Akram ^a   Ghazi, Farideh ^b   Rassoli, Homa ^c   Bakhtiari, Mehrdad ^c   Ataiy, Zohreh ^b   Soleimani, Sara ^d   Mehdizadeh, Mehdi ^c  

^a AJA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Coenzyme Q10; Neuroprotection; Parkinson's disease; Rats; Stromal cells derived from bone marrow

Indexed keywords

TYROSINE 3 MONOOXYGENASE; UBIDECARENONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL TRANSPLANTATION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; GENE EXPRESSION; GRAFT SURVIVAL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; STROMA CELL; TREATMENT OUTCOME; WISTAR RAT;

EID: 79960979925     PISSN: 09284680     EISSN: 1873149X     Source Type: Journal    
DOI: 10.1016/j.pathophys.2011.05.004     Document Type: Article

References (39)

1. Maraganore D.M., Harding A.E., Marsden C.D. A clinical and genetic study of familial Parkinson's disease. Mov. Disord. 1991, 6(3):205-211.
2. Kordower J.H., Goetz C.G. The first miracle in neurodegenerative disease: the discovery of oral levodopa. Brain Res. Bull. 1999, 50(5-6):377-378.
3. Suon S., Yang M., Iacovitti L. Adult human bone marrow stromal spheres express neuronal traits in vitro and in a rat model of Parkinson's disease. Brain Res. 2006, 1106(1):46-51.
4. Dauer W., Przedborski S. Parkinson's disease. Mechanisms and models. Neuron 2003, 39:889-909.
5. Wang Y., Chen S., Yang D., Le W.D. Stem cell transplantation: a promising therapy for Parkinson's disease. J. Neuroimmune Pharmacol. 2007, 2(3):243-250.
6. Yeu I.S., Lee H.J., Yi J.S., Yang J.H., Lee I.W., Lee H.K. The survival and migration pattern of the bone marrow stromal cells after intracerebral transplantation in rats. J. Kor. Neurosurg. Soc. 2004, 36(5):400-404.
7. Kan I., Ben-Zur T., Barhum Y., Levy Y.S., Burstein A., Charlow T., Bulvik S., Melamed E., Offen D. Dopaminergic differentiation of human mesenchymal stem cells-utilization of bioassay for tyrosine hydroxylase expression. Neurosci. Lett. 2007, 419(1):28-33.
8. Barry F.P., Murphy J.M., et al. Mesenchymal stem cells: clinical applications and biological characterization. Int. J. Biochem. Cell Biol. 2004, 36(4):568-584.
9. Ye M., Chen S., Wang X., Qi C., Lu G., Liang L., Xu J. Glial cell line-derived neurotrophic factor in bone marrow stromal cells of rat. Neuroreport 2005, 16(6):581-584.
10. Dezawa M., Ishikawa H., Hoshino M., Itokazu Y., Nabeshima Y. Potential of bone marrow stromal cells in applications for neurodegenerative, neuro-traumatic and muscle degenerative diseases. Curr. Neuropharmacol. 2005, 3(4):257-266.
11. Kordower J.H., Freeman T.B., Chen E.Y., Mufson E.J., Sanberg P.R., Hauser R.A., Snow B., Olanow C.W. Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease. Mov. Disord. 1998, 13(3):383-393.
12. Brundin P., Duan W.M., Sauer H. Functional effects of mesencephalic dopamine neurone and adrenal chromaffin cells grafted to the rodent striatum. Functional Neural Transplantation 1994, 9-46. Raven Press, New York. S.B. Dunnett, A. Bjorklund (Eds.).
13. Zawada W.M., Zastrow D.J., Clarkson E.D., Adams F.S., Bell K.P., Freed C.R. Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats. Brain Res. 1998, 786(1-2):96-103.
14. Mattson M.P. Modification of ion homeostasis by lipid peroxidation: roles in neuronal degeneration and adaptive plasticity. Trends Neurosci. 1998, 21(2):53-57.
15. Schierle G.S., Hansson O., Leist M., Nicotera P., Widner H., Brundin P. Caspase inhibition reduces apoptosis and increases survival of nigral transplants. Nat. Med. 1999, 5(1):97-100.
16. Yurek D.M., Lu W., Hipkens S., Wiegand S.J. BDNF enhances the functional reinnervation of the striatum by grafted fetal dopamine neurons. Exp. Neurol. 1996, 137(1):105-118.
17. Chaturvedi R.K., Agrawal A.K., Seth K., Shukla S., Chauhan S., Shukla Y., Sinha C., Seth P.K. Effect of glial cell line derived neurotrophic factor (GDNF) co-transplantation with fetal ventral mesencephalic cells (VMC) on functional restoration in 6-hydroxydopamine (6-OHDA) lesioned rat model of Parkinson's disease: neurobehavioral, neurochemical and immunohistochemical studies. Int. J. Dev. Neurosci. 2003, 21(7):391-400.
18. Dugan L.L., Lovett E.G., Quick K.L., Lotharius J., Lin T.T., O'Malley K.L. Fullerene-based antioxidants and neurodegenerative disorders. Parkinsonism Relat. Disord. 2001, 7(3):243-246.
19. Horvath T.L., Diano S., Leranth C., Garcia-Segura L.M., Cowley M.A., Shanabrough M., Elsworth J.D., Sotonyi P., Roth R.H., Dietrich E.H., Matthews R.T., Barnstable C.J., Redmond D.E. Coenzyme Q induces nigral mitochondrial uncoupling and prevents dopamine cell loss in a primate model of Parkinson's disease. Endocrinology 2003, 144(7):2757-2760.
20. Shults C.W. Therapeutic role of coenzyme Q(10) in Parkinson's disease. Pharmacol. Ther. 2005, 107(1):120-130.
21. Cleren C., Yang L., Lorenzo B., Calingasan N.Y., Schomer A., Sireci A., Wille E.J., Beal M.F. Therapeutic effects of coenzyme Q10 (CoQ10) and reduced CoQ10 in the MPTP model of parkinsonism. J. Neurochem. 2008, 104(6):1613-1621.
22. Müller T., Büttner T., Gholipour A.F., Kuhn W. Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with Parkinson's disease. Neurosci. Lett. 2003, 341(3):201-204.
23. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1986, Academic Press, San Diego, CA. 2nd edition.
24. Dezawa M., Takahashi I., Esaki M., Takano M., Sawada H. Sciatic nerve regeneration in rats induced by transplantation of in vitro differentiated bone-marrow stromal cells. Eur. J. Neurosci. 2001, 14(11):1771-1776.
25. Nakao N., Frodl E.M., Duan W.M., Widner H., Brundin P. Lazaroids improve the survival of grafted rat embryonic dopamine neurons. Proc. Natl. Acad. Sci. U.S.A. 1994, 91(26):12408-12412.
26. Agrawal A.K., Chaturvedi R.K., Shukla S., Seth K., Chauhan S., Ahmad A., Seth P.K. Restorative potential of dopaminergic grafts in presence of antioxidants in rat model of Parkinson's disease. J. Chem. Neuroanat. 2004, 28(4):253-264.
27. Kondo J.L., Kitarmura Y., Inden M., Masatoshi I., Taniguchi T. Hemiparkinsonian rat models: different sensitivity of dopaminergic neurotoxins. Int. Congr. Ser. 2004, 1260:281-285.
28. Agrawal A.K., Husain R., Raghubir R., Kumar A., Seth P.K. Neurobehavioral, neurochemical and electrophysiological studies in 6-hydroxydopamine lesioned and neural transplanted rats. Int. J. Dev. Neurosci. 1995, 13(2):105-111.
29. Ungerstedt U. Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour. Acta Physiol. Scand. Suppl. 1971, 367:49-68.
30. Bouchez G., Sensebé L., Vourc'h P., Garreau L., Bodard S., Rico A., Guilloteau D., Charbord P., Besnard J.C., Chalon S. Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease. Neurochem. Int. 2008, 52(7):1332-1342.
31. Ye M., Wang X.J., Zhang Y.H., Lu G.O., Liang L., Xu J.Y., Sheng-Di C. Therapeutic effects of differentiated bone marrow stromal cell transplantation on rat models of Parkinson's disease. Parkinsonism Relat. Disord. 2007, 13(1):44-49.
32. Matthews R.T., Yang L., Browne S., Baik M., Beal M.F. Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects. Proc. Natl. Acad. Sci. U.S.A. 1998, 95(15):8892-8897.
33. Okello E., Jiang X., Mohamed S., Zhao Q., Wang T. Combined statin/coenzyme Q10 as adjunctive treatment of chronic heart failure. Med. Hypotheses 2009, 73(3):306-308.
34. Papucci L., Schiavone N., Witort E., Donnini M., Lapucci A., Tempestini A., Formigli L., Zecchi-Orlandini S., Orlandini G., Carella G., Brancato R., Capaccioli S. Coenzyme q10 prevents apoptosis by inhibiting mitochondrial depolarization independently of its free radical scavenging property. J. Biol. Chem. 2003, 278(30):28220-28228.
35. Shintani A., Nakao N., Kakishita K., Itakura T. Protection of dopamine neurons by bone marrow stromal cells. Brain Res. Brain Res. 2007, 1186:48-55.
36. Lu D., Mahmood A., Wang L., Li Y., Lu M., Chopp M. Adult bone marrow stromal cells administered intravenously to rats after traumatic brain injury migrate into brain and improve neurological outcome. Neuroreport 2001, 12(3):559-563.
37. Zhao L.R., Duan W.M., Reyes M., Keene C.D., Verfaillie C.M., Low W.C. Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats. Exp. Neurol. 2002, 174(1):11-20.
38. Li Y., Chen J., Wang L., Zhang L., Lu M., Chopp M. Intracerebral transplantation of bone marrow stromal cells in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurosci. Lett. 2002, 316:67-70.
39. Hansson O., Castilho R.F., Kaminski Schierle G.S., Karlsson J., Nicotera P., Leist M., Brundin P. Additive effects of caspase inhibitor and lazaroid on the survival of transplanted rat and human embryonic dopamine neurons. Exp. Neurol. 2000, 164(1):102-111.